skip to content

Cambridge Biosciences DTP PhD Programme

 
Kyle Reid-Frontiers in Immunology

Congratulations to Kyle Reid, 2019 cohort PhD student on the BBSRC DTP programme, for publishing the Research Article ‘Brain Cells Release Calreticulin That Attracts and Activates Microglia, and Inhibits Amyloid Beta Aggregation and Neurotoxicity’ in Frontiers in Immunology.

 

Here, Kyle and colleagues show that the protein calreticulin is released by microglia and neurons in the brain, and acts: as an alarmin to recruit and activate microglia, as an extracellular chaperone to prevent Aβ aggregation, and as a neuroprotectant against Aβ neurotoxicity.

 

Abstract:

Calreticulin is a chaperone, normally found in the endoplasmic reticulum, but can be released by macrophages into the extracellular medium. It is also found in cerebrospinal fluid bound to amyloid beta (Aβ). We investigated whether brain cells release calreticulin, and whether extracellular calreticulin had any effects on microglia and neurons relevant to neuroinflammation and neurodegeneration. We found that microglia release nanomolar levels of calreticulin when inflammatory-activated with lipopolysaccharide, when endoplasmic reticulum stress was induced by tunicamycin, or when cell death was induced by staurosporine, and that neurons release calreticulin when crushed. Addition of nanomolar levels of extracellular calreticulin was found to chemoattract microglia, and activate microglia to release cytokines TNF-α, IL-6 and IL-1β, as well as chemokine (C-C motif) ligand 2. Calreticulin blocked Aβ fibrillization and modified Aβ oligomerization, as measured by thioflavin T fluorescence and transmission electron microscopy. Extracellular calreticulin also altered microglial morphology and proliferation, and prevented Aβ-induced neuronal loss in primary neuron-glial cultures. Thus, calreticulin is released by microglia and neurons, and acts: as an alarmin to recruit and activate microglia, as an extracellular chaperone to prevent Aβ aggregation, and as a neuroprotectant against Aβ neurotoxicity.

To read the full publication, please click here
Reid, K.M. et al. (2022). Brain Cells Release Calreticulin That Attracts and Activates Microglia, and Inhibits Amyloid Beta Aggregation and Neurotoxicity. Front Immunol., 13 (859686): pp. 1-12.

Latest news

Welcome to our new BBSRC DTP cohort 2023!

10 October 2023

After a three-year funding gap, we are thrilled to announce the arrival of a fresh cohort of DTP students, generously funded by the Biotechnology and Biological Sciences Research Council (BBSRC). Building on last year's successful securing of funding for DTP3, this October marks the commencement of the first cohort, with another set to follow next year.

Cambridge Biosciences DTP student, Maximilian Gantz, wins First Prize for ‘best talk’ at the Department of Biochemistry PhD Symposium

3 October 2023

Max (SBS DTP, cohort 2020), PhD student in Prof. Florian Hollfelder’s lab, was one of the 17 students presenting at the Department of Biochemistry PhD Symposium. His talk, with the title ‘A Microfluidics-enabled Workflow for Rapid Large-scale Fitness Data Generation Informs Biocatalyst Engineering’, won First prize for "best oral presentation".

New Training and Inclusivity Support Manager has been appointed to support our DTP cohorts

27 September 2023

We are thrilled to announce the appointment of Dr Sam Byers as the Training and Inclusivity Support Manager for the Cambridge Biosciences DTP cohorts.